Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials
Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment.
No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving
Patient outcomes after tricuspid valve replacement have improved significantly over the years, according to new data published in The Annals of Thoracic Surgery.
Implantable IVC sensor shows early potential to guide heart failure management
The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device.
New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'
Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab."

Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis.

Video of Michael Reardon, MD, explaining details from the Evolute Low Risk 4-year results at TCT 2023.

TAVR triumphs over surgery: Exploring 4-year data from the Evolut Low Risk trial

Michael Reardon, MD, discussed his team's late-breaking results at TCT 2023 in San Francisco.

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Portfolio diet—which focuses on plant-based, cholesterol-lowering foods—reduces risk of heart disease and stroke

While it is not as well-known as some other heart-healthy diets, the portfolio diet is linked to key cardiovascular benefits. "We need to get the word out," one dietitian said.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

Mount Sinai renames leading heart hospital after cardiologist Valentin Fuster

Fuster, one of the world's most celebrated cardiologists, currently serves as the hospital’s president and physician-in-chief.

The Evoque transcatheter tricuspid valve replacement (TTVR) system for tricuspid regurgitation from Edwards Lifesciences

More good news for Edwards: ‘Landmark study’ confirms new TTVR system reduces tricuspid regurgitation, improves symptoms

New data presented at TCT 2023 suggest the Evoque tricuspid valve replacement system could make a significant impact on the lives of patients with severe TR.

HeartPoint Global Shark Tank Intellistent

New pediatric interventional device for PAH wins ‘Shark Tank’ event at TCT 2023

The first-place finish earned HeartPoint Global $20,000 in prize money.

Late-breaking clinical trials at TCT 2023 could lead to FDA approvals for Abbott, Boston Scientific

Will a coronary drug-coated balloon finally gain full approval from the FDA? New data presented at TCT 2023 seems to suggest it just might happen.

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

Cardiology Associations

AI-based coronary plaque evaluations highlight elevated heart risks in women

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials

No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving

Implantable IVC sensor shows early potential to guide heart failure management

New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'